12.01.2017 • NewsAzelisBiocidesDistribution Agreement

Lonza Extends Its Distribution Relationship with Azelis

© Azelis
© Azelis

Lonza expanded its distribution agreement with Azelis in Europe with effect from Jan. 1, 2017. The company will offer Lonza’s materials protection ingredients to industrial market segments such as paints, coatings, inks, emulsion polymerisation, adhesives and sealants, marine paints, building products, construction auxiliaries and mineral slurries. The new mandate covers Germany, Switzerland, United Kingdom, Benelux, Bulgaria, Slovenia, Croatia, Serbia and Ukraine. Azelis has already been serving Lonza in France and Italy for more than ten years and in Turkey since 2015.

Per Westin, head of Global Sales, Coatings & Composites SBU Lonza, comments: “We chose Azelis because of their ability to offer customer service and satisfaction through experience, knowledge of the products and applications and their approach to product stewardship and regulatory compliance. We are looking forward to working with Azelis in this expanded partnership.”

To support the development of its biocide business, Azelis has hired Gilles Pradier as business development manager for this segment. Pradier is a biocide specialist with over 20 years’ experience in marketing and sales of industrial biocides. He will be based in the Azelis Paris office.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.